ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 140 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,208,647 | -26.4% | 110,102 | +3.6% | 0.00% | -25.0% |
| Q2 2023 | $2,999,344 | +881.7% | 106,322 | +498.5% | 0.00% | – |
| Q1 2023 | $305,541 | -14.6% | 17,764 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $357,767 | -7.0% | 17,764 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $384,768 | -4.3% | 17,764 | +24.1% | 0.00% | 0.0% |
| Q2 2022 | $402,000 | -39.1% | 14,312 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $660,000 | -44.0% | 14,312 | +2.1% | 0.00% | -50.0% |
| Q4 2021 | $1,179,000 | +28.3% | 14,020 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $919,000 | +32.2% | 13,794 | +5.6% | 0.00% | +100.0% |
| Q2 2021 | $695,000 | +27.8% | 13,061 | +4.1% | 0.00% | 0.0% |
| Q1 2021 | $544,000 | -12.4% | 12,548 | +5.0% | 0.00% | 0.0% |
| Q4 2020 | $621,000 | – | 11,949 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
| Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
| Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
| Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
| Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
| Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
| Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
| HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
| Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |